XML 27 R16.htm IDEA: XBRL DOCUMENT v3.25.3
Income Taxes
 9 Months Ended
Nov. 01, 2025
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Effective Income Tax Rate
Income tax expense (benefit) for the interim periods is computed using the income tax rate estimated to be applicable for the full fiscal year, adjusted for discrete items. The Company’s effective income tax rate was an expense of 59.6% for the nine months ended November 1, 2025 compared to 355.1% for the nine months ended November 2, 2024. The change in the effective income tax rate was primarily due to a shift in the distribution of earnings among the Company’s tax jurisdictions and to the Company’s lower income during the nine months ended November 1, 2025 compared to the same prior-year period. The rate was also affected by a net $14.8 million unrealized gain during the nine months ended November 1, 2025 compared to a net $41.8 million unrealized loss during the same prior-year period on the fair value remeasurement of derivatives related to the Company's 2028 Notes and the related convertible note hedge, which was disregarded for income tax purposes.
Unrecognized Income Tax Benefit
The Company and its subsidiaries are subject to U.S. federal and foreign income tax, as well as income tax of multiple state and foreign local jurisdictions. From time-to-time, the Company is subject to routine income and other audits on various income tax matters around the world in the ordinary course of business. As of November 1, 2025, no income tax or other tax audits expected to have a material impact on the Company’s financial statements were ongoing.
As of November 1, 2025 and February 1, 2025, the Company had $43.1 million and $40.3 million, respectively, of aggregate accruals for uncertain income tax positions, including penalties and interest. This includes an accrual of $20.6 million, excluding interest and penalties, for a fiscal 2022 intra-entity transfer of
intellectual property rights from certain U.S. entities to a wholly-owned Swiss subsidiary, substantially offset by the related deferred income tax benefit recorded by the Swiss subsidiary. The Company reviews and updates the estimates used in the accrual for uncertain income tax positions, as appropriate, as more definitive information or interpretations become available from income taxing authorities, and on the completion of income tax audits, the receipt of assessments, expiration of statutes of limitations, or occurrence of other events.
During fiscal 2021, the Company became aware of a foreign withholding income tax regulation that could be interpreted to apply to certain of its previous transactions. The Company currently does not expect its exposure, if any, will have a material impact on its consolidated financial position, results of operations or cash flows.
Indefinite Reinvestment Assertion
The Company has historically considered the undistributed earnings of its foreign subsidiaries to be indefinitely reinvested. As a result of the 2017 Tax Cuts and Jobs Act, the Company had a substantial amount of previously taxed earnings that could be distributed to the United States without additional U.S. taxation. As of November 1, 2025, the Company determined that approximately $300.0 million of such foreign earnings are not indefinitely reinvested. The incremental tax cost to repatriate these earnings to the United States is immaterial. The Company intends to indefinitely reinvest the remaining earnings from the Company’s foreign subsidiaries for which a deferred income tax liability has not already been recorded. The Company continues to evaluate its plans for reinvestment or repatriation of unremitted foreign earnings and regularly reviews its cash positions and determination of indefinite reinvestment of foreign earnings. If the Company determines that all or a portion of such foreign earnings are no longer indefinitely reinvested, the Company may be subject to additional foreign withholding taxes and U.S. state income taxes beyond the one-time transition tax.
Recent Tax Law Changes
On July 4, 2025, the One Big Beautiful Bill Act of 2025 (the “2025 Tax Act”) was signed into law, introducing several changes to U.S. corporate income tax provisions. Key provisions include the reinstatement of 100% accelerated depreciation on qualified property and a return to an EBITDA-based calculation for interest expense limitations under Section 163(j) of the Internal Revenue Code of 1986, as amended. While the Company continues to assess the full impact of the 2025 Tax Act, the legislation did not have a material effect on the Company’s condensed consolidated financial statements for the three or nine months ended November 1, 2025.